Author

Adee Kennedy

Observed names: A Kennedy, ADEE KENNEDY

Institutions: Sanofi (France), Sanofi (United States)

Observed institutions: Harvard University, Kaiser Permanente Washington Health Research Institute, Sanofi (France), Harvard Pilgrim Health Care, Sanofi (United States)

ORCID: 0009-0003-7402-0047

Observed ORCID: 0009-0003-7402-0047

OpenAlex ID: A5083755872

Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning

2022 · David S Carrell, Susan Gruber, et al. · American Journal of Epidemiology · 35

Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies

2021 · Vincent Lo Re, Dean M. Carbonari, et al. · Pharmacoepidemiology and Drug Safety · 29

Electronic phenotyping of health outcomes of interest using a linked claims-electronic health record database: Findings from a machine learning pilot project

2021 · Teresa B Gibson, Michael D Nguyen, et al. · Journal of the American Medical Informatics Association · 20

A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes

2024 · Onyinye Diribe, Karen Palmer, et al. · Diabetes Therapy · 11

Evaluation of Use of Technologies to Facilitate Medical Chart Review

2019 · Loreen Straub, Joshua J. Gagne, et al. · Drug Safety · 11

Medical chart validation of inpatient diagnosis codes for transfusion‐related acute lung injury 2013‐2015

2021 · Candace C. Fuller, Vinod E. Nambudiri, et al. · Transfusion · 10

Extension of Disease Risk Score–Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation

2018 · Rishi J Desai, Richard Wyss, et al. · American Journal of Epidemiology · 9

Patient and Physician Perspectives on the Use of a Connected Ecosystem for Diabetes Management: International Cross-Sectional Observational Study

2023 · Elizabeth Benito-Garcia, Julio Vega, et al. · JMIR Formative Research · 3

Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes

2024 · John D Piette, Keni C S Lee, et al. · Translational Behavioral Medicine · 2

962-P: Impact of Digital Diabetes Solution on Glycemic Control in Adults with Type 2 Diabetes Mellitus in the United States—A Retrospective Cohort Study

2023 · NITA THINGALAYA, DAVID KERR, et al. · Diabetes · 2

126-LB: Effect of a Digital Diabetes Solution on All-Cause Health Care Resource Utilization Charges for Patients with Type 2 Diabetes—A Retrospective Cohort Study

2023 · LAURA WILSON, DANIEL C. MALONE, et al. · Diabetes · 1

Progression of Heart Failure in People with Type 2 Diabetes in Germany: An Analysis Using German Health Insurance Claims Data

2024 · Keni Cheng-Siang Lee, Tobias Wagner, et al. · Journal of health economics and outcomes research

Disease progression of heart failure in type 2 diabetes patients in Germany; a real world data analysis using health insurance claims data

2022 · K Lee, M Wilke, et al. · European Heart Journal

Works count: 13

Citation count: 133

H-index: 7

I10-index: 6